Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Oxford Immunotec Global plc (Nasdaq: OXFD)

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The Company’s first product is the T-SPOT®.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company’s second product line is a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Also obtained through the acquisitions is the Company’s third product line focused on screening for Babesia in donated blood, for which the Company is currently seeking FDA licensure. The T-SPOT.CMV test and the T-SPOT.PRT test are pipeline products as part of the Company’s fourth intended product line focused on the transplantation market. In addition to these four product lines, the Company has additional active development programs in other immune-regulated conditions. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass. *

 

Period Start 2013-11-22 existent
  Group Oxford Immunotec (Group)
Product Industry diagnostics (medical/biological)
     
Region Region Abingdon, Oxfordshire
  Country United Kingdom (GB)
  Street 115D Innovation Drive
Milton Park
  City OX14 4RZ Abingdon, Oxfordshire
  Tel +44-1235-442-780
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2020-09-30)
  Currency USD
  Annual sales 62,800,000 (revenue, total (2015) 2015-12-31)
  Profit -24,500,000 (2015-12-31)
  Cash 83,700,000 (2015-12-31)
     
    * Document for »About Section«: Oxford Immunotec Global plc. (8/30/17). "Press Release: Oxford Immunotec to Present at the Baird 2017 Global Healthcare Conference". Oxford & Marlborough, MA.
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Oxford Immunotec (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top